Considering HUMIRA for Hidradenitis Suppurativa?
HUMIRA and Hidradenitis Suppurativa
Significant results in just 3 months.
HUMIRA was studied in over 600 adult patients like you with Hidradenitis Suppurativa — the largest clinical trials completed for HS to date.
HUMIRA was shown to provide a clinically significant response after 12 weeks of treatment to a substantial proportion of patients (40-60%). Your results may vary.
Humira for HS in New Zealand
HUMIRA is only available on prescription for adults and adolescents from 12 years and older with Hidradenitis Suppurativa. Talk to your Dermatologist or specialist to see if HUMIRA is right for them.
The government medicine funding agency, PHARMAC, fully subsidises HUMIRA for Hidradenitis Suppurativa if they have not fully responded to other medicines prescribed by a specialist, and you meet other criteria required by PHARMAC. Your specialist will discuss whether HUMIRA is right for you, and whether you qualify for PHARMAC funded treatment. Usual doctor’s consultation fees, and pharmacy prescription charges remain payable by you.